HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, Jan. 19, 2018 (HealthDay News) -- The risk of psychotic experiences is increased with cannabis use during adolescence, according to a study published online Jan. 17 in JAMA Psychiatry.
Hannah J. Jones, Ph.D., from the University of Bristol in the United Kingdom, and colleagues used data from the Avon Longitudinal Study of Parents and Children to examine the association of cigarette and cannabis use with preceding and subsequent psychotic experiences. Associations between longitudinal classes of substance use and psychotic experiences at age 18 were assessed for 5,300 participants with at least three measures of cigarette and cannabis use from ages 14 to 19 years.
The researchers found strong evidence that early-onset cigarette-only use, early-onset cannabis use, and late-onset cannabis use were correlated with increased psychotic experiences compared with nonuse before adjustment for a range of potential confounders. The association for early-onset cigarette-only use was attenuated substantially after adjustment for confounders (unadjusted odds ratio, 3.03 [95 percent confidence interval, 1.13 to 8.14]; adjusted odds ratio, 1.78 [95 percent confidence interval, 0.54 to 5.88]); for early-onset cannabis use and late-onset cannabis use, the correlations remained consistent (adjusted odds ratios, 3.7 [95 percent confidence interval, 1.66 to 8.25] and 2.97 [95 percent confidence interval, 1.63 to 5.4], respectively).
"Our findings indicate that while individuals who use cannabis or cigarettes during adolescence have an increased risk of subsequent psychotic experiences, epidemiological evidence is substantively more robust for cannabis use than it is for tobacco use," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 28, 2022